For the Inventor, By the Inventor

Enter assignee name

Basel, Switzerland

Pentapharm Ag

Calculating rank

USPTO Granted Patents = 32

% Expired Patents = 3.1

Trademarks = 17

Forward Citations = 478

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Lars G Svendsen (12 out of 12 patents)

Kurt F Stocker (8 out of 9 patents)

Peter Wikstroem (3 out of 13 patents)

4. Douglas A Triplett (3 out of 3 patents)

5. Helmut Vieweg (2 out of 4 patents)

6. Thomas Schreier (2 out of 2 patents)

7. Rainer Voegeli (2 out of 2 patents)

8. Peter E Ries (2 out of 2 patents)

9. Andreas Calatzis (1 out of 13 patents)

10. Hugo Ziegler (1 out of 39 patents)

11. Roland Jermann (1 out of 2 patents)

12. Jörg Stürzebecher (1 out of 7 patents)

13. Patrizia Maria Gempeler (1 out of 1 patent)

14. Carlo Ghisalberti (1 out of 2 patents)

15. Franck Moisio (1 out of 1 patent)

Core Competencies:

Anticoagulants

Hematological Assay

Peptide Derivatives

Thrombin Inhibitors

Protein C System

Electrochemical Measurement

Self-Tanning Properties

Lyophilized Products

Cosmetic Care

Collagen Products

Enzyme Assays

Protease Activity

32 patents: Sort by Forward Citations

1. 11846640 - Identification of anticoagulants in a sample (2023-12-19),

2. 6994984 - Hematological assay (2006-02-07),

3. 6953583 - Use of conjugated linoleic acid (CLA) for the topical treatment of cellulite (2005-10-11),

4. 6880728 - Closure cap (2005-04-19),

5. 6861435 - Urokinase inhibitors (2005-03-01),

6. 6495336 - Oligopeptide derivatives for the electrochemical measurement of protease activity (2002-12-17),

7. 6451559 - Expression vector for improved production of polypeptides in yeast (2002-09-17),

8. 6451293 - Combination of erythrulose and a reducing sugar with self-tanning properties (2002-09-17),

9. 6426192 - Method for the functional detection of disorders in the protein C system (2002-07-30),

10. 6237649 - Dual vial connecting system for lyophilized products (2001-05-29),

11. 5922587 - Phospholipid dependent prothrombin activator obtained from snake venom (1999-07-13),

12. 5705198 - Test for lupus anticoagulant (1998-01-06),

13. 5607937 - Piperazides of substituted phenylalanine derivatives as thrombin (1997-03-04),

14. 5518735 - Meta-substituted phenylalanine derivatives (1996-05-21),

15. 5453370 - Method for the preparation of a phospholipid-dependent prothrombin (1995-09-26),

Company Overview

Pentapharm AG, based in Basel, Switzerland, specializes in the development and manufacturing of high-quality active pharmaceutical ingredients and excipients. The company focuses on innovative solutions for the pharmaceutical and cosmetic industries, leveraging advanced technologies to enhance product efficacy and safety. With a commitment to research and development, Pentapharm AG aims to address the evolving needs of its clients while adhering to stringent quality standards in a competitive global market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

32 Patents

#18 in Basel

#425 in Switzerland

#20,712 in the World

Basel, Switzerland

Pentapharm Ag

Forward Citations = 478

29 inventors:

Lars G Svendsen (12 out of 12 patents)

Kurt F Stocker (8 out of 9 patents)

Peter Wikstroem (3 out of 13 patents)

4. Douglas A Triplett (3 out of 3 patents)

5. Helmut Vieweg (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pentapharm Ag. Retrieved from https://idiyas.com/company/pentapharm-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…